Tulavi Therapeutics
Patrick Chiu has over 17 years of experience in finance. Patrick started their career at Monogram Biosciences in 2005 as a Financial Reporting Manager. In 2008, they moved to Access Closure, Inc. as a Director of Financial Planning & Analysis. In 2014, they were promoted to the same role at Cardinal Health. In 2017, they joined Imperative Care as a Sr. Director of Financial Planning & Analysis. Most recently, in 2022, they were promoted to Sr. Director of Finance at Tulavi Therapeutics.
Patrick Chiu earned an MBA from San Francisco State University's Lam Family College of Business in 2002.
Tulavi Therapeutics
1 followers
Tulavi is a biomedical company dedicated to making better nerve care more accessible. By engineering simple, elegant solutions to restore nerve balance, Tulavi strives to ensure that caregivers have access to effective, easy-to-use solutions that equip them to proactively prevent nerve pain, promote nerve regeneration and provide a higher standard of patient nerve care.